Identification of immunity-related genes in prostate cancer and potential role of the ETS family of transcription factors in their regulation.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  International Journal of Molecular Medicine

• Publication date

  2011-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/ijmm.2011.771PMID 21833467
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prostate cancer immunology – an update for Urologists

  2011influential reference
• Identification and validation of SAA as a potential lung cancer biomarker and its involvement in metastatic pathogenesis of lung cancer.

  2011cited by this paper
• Functional Roles of Src and Fgr in Ovarian Carcinoma

  2011cited by this paper
• Identification and validation of highly frequent CpG island hypermethylation in colorectal adenomas and carcinomas

  2011cited by this paper
• Does prolactin induce apoptosis? Evidences in a prostate cancer in vitro model

  2010cited by this paper
• Angiotensin-converting enzymes (ACE and ACE2) are downregulated in renal tumors.

  2010cited by this paper
• HDAC5 and HDAC9 in Medulloblastoma: Novel Markers for Risk Stratification and Role in Tumor Cell Growth

  2010cited by this paper
• Immune Signatures Predict Prognosis in Localized Cancer

  2010influential reference
• CXCL9 induces chemotaxis, chemorepulsion and endothelial barrier disruption through CXCR3-mediated activation of melanoma cells

  2010cited by this paper
• Expression of Serum Amyloid A in Human Ovarian Epithelial Tumors: Implication for a Role in Ovarian Tumorigenesis

  2010cited by this paper
• research paper: Differential expression of HDAC3, HDAC7 and HDAC9 is associated with prognosis and survival in childhood acute lymphoblastic leukaemia

  2010cited by this paper
• Unexploited therapies in breast and prostate cancer: blockade of the prolactin receptor.

  2010cited by this paper
• Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity.

  2010cited by this paper
• Nitric oxide synthase 2 gene polymorphisms are associated with prostatic volume in Korean men with benign prostatic hyperplasia.

  2010cited by this paper
• CXCR3/ligands are significantly involved in the tumorigenesis of basal cell carcinomas.

  2010cited by this paper
• Host-derived interleukin-5 promotes adenocarcinoma-induced malignant pleural effusion.

  2010cited by this paper
• HDAC 5 and HDAC 9 in Medulloblastoma : Novel Markers for Risk Stratification and Role in Tumor Cell Growth

  2010cited by this paper
• A novel axis of innate immunity in cancer

  2010cited by this paper
• Microarray gene expression profiling in meningiomas: differential expression according to grade or histopathological subtype.

  2009cited by this paper
• Decreased expression of angiotensin-converting enzyme 2 in pancreatic ductal adenocarcinoma is associated with tumor progression.

  2009cited by this paper
• CD4+ lymphocytes modulate prostate cancer progression in mice

  2009cited by this paper
• Recurrent gene fusions in prostate cancer

  2008cited by this paper
• Elevated expression of SerpinA1 and SerpinA3 in HLA‐positive cervical carcinoma

  2008cited by this paper
• Prostatic preneoplasia and beyond.

  2008cited by this paper
• Identification of new genes associated with breast cancer progression by gene expression analysis of predefined sets of neoplastic tissues

  2008cited by this paper
• Association of Cysteine-Rich Secretory Protein 3 and β-Microseminoprotein with Outcome after Radical Prostatectomy

  2007cited by this paper
• Profile of Ets gene expression in human breast carcinoma

  2007cited by this paper
• ETV1 is a novel androgen receptor-regulated gene that mediates prostate cancer cell invasion.

  2007cited by this paper
• Genome-wide analyses reveal properties of redundant and specific promoter occupancy within the ETS gene family.

  2007cited by this paper
• Nox1 expression determines cellular reactive oxygen and modulates c-fos-induced growth factor, interleukin-8, and Cav-1.

  2007cited by this paper
• Global Expression Analysis of Prostate Cancer-associated Stroma and Epithelia

  2007cited by this paper
• WHAT IS THE ROLE OF INFLAMMATION IN THE PATHOGENESIS OF PROSTATE CANCER?

  2007cited by this paper
• A cytokine-mediated link between innate immunity, inflammation, and cancer.

  2007influential reference
• Function, structure and therapeutic potential of complement C5a receptors

  2007cited by this paper
• Silencing of lactotransferrin expression by methylation in prostate cancer progression

  2007cited by this paper
• Prostate tumor CXC-chemokine profile correlates with cell adhesion to endothelium and extracellular matrix.

  2006cited by this paper
• Cancer immunomics: using autoantibody signatures in the early detection of prostate cancer.

  2006cited by this paper
• ETS transcription factors and regulation of immunity

  2006cited by this paper
• Human peptidoglycan recognition protein S is an effector of neutrophil-mediated innate immunity.

  2005cited by this paper
• CDKN2A common variants and their association with melanoma risk: a population-based study.

  2005cited by this paper
• CDKN 2 A Common Variants and Their Association with Melanoma Risk : A Population-Based Study

  2005cited by this paper
• Prostate cancer immunology: biology, therapeutics, and challenges.

  2005cited by this paper
• RNA interference targeting of A1 receptor-overexpressing breast carcinoma cells leads to diminished rates of cell proliferation and induction of apoptosis

  2005cited by this paper
• Increased Nox1 and hydrogen peroxide in prostate cancer

  2005cited by this paper
• Ets-1 expression promotes epithelial cell transformation by inducing migration, invasion and anchorage-independent growth

  2005cited by this paper
• Laser-assisted microdissection, techniques and applications in pathology (review).

  2005cited by this paper
• The role of interleukin-2 receptor alpha in cancer.

  2005cited by this paper
• Stage‐dependent increase of orosomucoid and zinc‐alpha2‐glycoprotein in urinary bladder cancer

  2005cited by this paper
• In Vivo Gene Transfer Using Direct Intramuscular Injection Approach

  2004cited by this paper
• Functional differences between integrin alpha4 and integrins alpha5/alphav in modulating the motility of human oral squamous carcinoma cells in response to the V region and heparin-binding domain of fibronectin.

  2004cited by this paper
• Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate

  2004cited by this paper
• Alteration in Copy Numbers of Genes as a Mechanism for Acquired Drug Resistance

  2004cited by this paper
• Expression profiles frame the promoter specificity dilemma of the ETS family of transcription factors.

  2004cited by this paper
• The adaptor protein SH2D1A regulates signaling through CD150 (SLAM) in B cells.

  2004cited by this paper
• Natural killer cells and innate immunity to protozoan pathogens.

  2004cited by this paper
• Peptidoglycan Recognition Protein Tag7 Forms a Cytotoxic Complex with Heat Shock Protein 70 in Solution and in Lymphocytes*

  2004cited by this paper
• Expression of the SH2D1A gene is regulated by a combination of transcriptional and post‐transcriptional mechanisms

  2004cited by this paper
• ETS transcription factors: Possible targets for cancer therapy

  2004cited by this paper
• Functional differences between integrin α4 and integrins α5/αv in modulating the motility of human oral squamous carcinoma cells in response to the V region and heparin-binding domain of fibronectin

  2004cited by this paper
• Tumorigenesis and Neoplastic Progression Heterogeneity in Primary and Metastatic Prostate Cancer as Defined by Cell Surface CD Profile

  2004cited by this paper
• Natural killer cells and cancer.

  2003cited by this paper
• Influence of histochemical stains on quantitative gene expression analysis after laser-assisted microdissection.

  2003cited by this paper
• An intronic alternative promoter of the human lactoferrin gene is activated by Ets.

  2003cited by this paper
• Identification of tumor‐associated antigens by screening phage‐displayed human cDNA libraries with sera from tumor patients

  2003cited by this paper
• The Ets-1 transcription factor is involved in the development and invasion of malignant melanoma

  2003cited by this paper
• Tumour‐associated antigens in multiple myeloma

  2003cited by this paper
• Cysteine-rich secretory protein-3: a potential biomarker for prostate cancer.

  2002cited by this paper
• Analysis of microdissected prostate tissue with ProteinChip arrays--a way to new insights into carcinogenesis and to diagnostic tools.

  2002cited by this paper
• Opposing Effects of 15-Lipoxygenase-1 and -2 Metabolites on MAPK Signaling in Prostate

  2002cited by this paper
• NK cells and NKT cells in innate defense against viral infections.

  2001cited by this paper
• The BCL 11 gene family : involvement of BCL 11 A in lymphoid malignancies

  2001cited by this paper
• The BCL11 gene family: involvement of BCL11A in lymphoid malignancies.

  2001cited by this paper
• Overexpression of 15-lipoxygenase-1 in PC-3 human prostate cancer cells increases tumorigenesis.

  2001cited by this paper
• Reduced infiltration of tumor-associated macrophages in human prostate cancer: association with cancer progression.

  2000cited by this paper
• DMBT1 encodes a protein involved in the immune defense and in epithelial differentiation and is highly unstable in cancer.

  2000cited by this paper
• Cutting Edge: The Ets1 Transcription Factor Is Required for the Development of NK T Cells in Mice1

  2000cited by this paper
• Concordant induction of 15-lipoxygenase-1 and mutant p53 expression in human prostate adenocarcinoma: correlation with Gleason staging.

  2000cited by this paper
• Regulation of the Human Interleukin-5 Promoter by Ets Transcription Factors

  1999cited by this paper
• A composite C/EBP binding site is essential for the activity of the promoter of the IL-3/IL-5/granulocyte-macrophage colony-stimulating factor receptor beta c gene.

  1999cited by this paper
• Cloning and characterization of the human interleukin-3 (IL-3)/IL-5/ granulocyte-macrophage colony-stimulating factor receptor betac gene: regulation by Ets family members.

  1998cited by this paper
• A Survey of the Humoral Immune Response of Cancer Patients to a Panel of Human Tumor Antigens

  1998cited by this paper
• Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL

  1998cited by this paper
• A peptidoglycan recognition protein in innate immunity conserved from insects to humans.

  1998cited by this paper
• The Ets-1 transcription factor is required for the development of natural killer cells in mice.

  1998cited by this paper
• Databases on transcriptional regulation : TRANSFAC , TRRD and COMPEL

  1997influential reference
• Loss of uteroglobin expression in prostate cancer: relationship to advancing grade.

  1997cited by this paper
• DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3–26.1 is deleted in malignant brain tumours

  1997cited by this paper
• HISTOLOGICAL GRADE HETEROGENEITY IN MULTIFOCAL PROSTATE CANCER. BIOLOGICAL AND CLINICAL IMPLICATIONS

  1996cited by this paper
• Association between orosomucoid types and cancer.

  1995cited by this paper
• An intricate arrangement of binding sites for the Ets family of transcription factors regulates activity of the alpha 4 integrin gene promoter.

  1994cited by this paper
• Histological grade, perineural infiltration, tumour-infiltrating lymphocytes and apoptosis as determinants of long-term prognosis in prostatic adenocarcinoma.

  1994cited by this paper
• Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes

  1994cited by this paper
• The Ets family of transcription factors.

  1993cited by this paper
• Differential molecular mechanism of the estrogen action that regulates lactoferrin gene in human and mouse.

  1992cited by this paper
• Growth inhibition of human pancreatic cancer cells by cholecystokinin receptor antagonist in tissue culture and in nude mice

  1992cited by this paper
• Evolutionarily conserved Ets family members display distinct DNA binding specificities [published erratum appears in J Exp Med 1993 Sep 1;178(3):1133]

  1992cited by this paper

• MiR-378 suppresses prostate cancer cell growth through downregulation of MAPK1 in vitro and in vivo

  2016cites this paper
• MiR-223-3p targeting SEPT6 promotes the biological behavior of prostate cancer

  2014cites this paper
• Regulation of prostate cancer immunity-related genes in PC3 prostate cancer cells by ETS-1.

  2012cites this paper
• MicroRNA‐23b downregulates peroxiredoxin III in human prostate cancer

  2012cites this paper
• 2. ETS gene fusions in prostate cancer 3. Expression of the ETS family in prostate cancer 4. The roles of the ETS-family prototype ETS-1 in prostate cancer 5. ETS-1, a potential regulator of the ETS-family in prostate cancer

  2012cites this paper
• ERG is specifically associated with ETS-2 and ETV-4, but not with ETS-1, in prostate cancer

  2012cites this paper
• ETS transcription factors and prostate cancer: the role of the family prototype ETS-1 (review).

  2012cites this paper
• Prognostic markers in prostate cancer : studies of a watchful waiting cohort with long follow up

  2011cites this paper